Overview

Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate pharmacodynamic effects and pharmacokinetics of KUC 7483
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
p-Hydroxyamphetamine